Alnylam Pharmaceuticals
ALNY
#629
Rank
โ‚น3.806 T
Marketcap
โ‚น28,512
Share price
0.67%
Change (1 day)
23.76%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company